220 related articles for article (PubMed ID: 21497407)
1. Upregulation of heme oxygenase-1 expression by hydroxysafflor yellow A conferring protection from anoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes.
Liu SX; Zhang Y; Wang YF; Li XC; Xiang MX; Bian C; Chen P
Int J Cardiol; 2012 Oct; 160(2):95-101. PubMed ID: 21497407
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway.
Min J; Wei C
Biomed Pharmacother; 2017 Mar; 87():419-426. PubMed ID: 28068632
[TBL] [Abstract][Full Text] [Related]
3. Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
Hu T; Wei G; Xi M; Yan J; Wu X; Wang Y; Zhu Y; Wang C; Wen A
Int J Mol Med; 2016 Jul; 38(1):83-94. PubMed ID: 27176815
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade.
Wei G; Yin Y; Duan J; Guo C; Zhu Y; Wang Y; Xi M; Wen A
Biomed Pharmacother; 2017 Apr; 88():409-420. PubMed ID: 28122306
[TBL] [Abstract][Full Text] [Related]
5. Hydroxysafflor yellow a protects brain microvascular endothelial cells against oxygen glucose deprivation/reoxygenation injury: Involvement of inhibiting autophagy via class I PI3K/Akt/mTOR signaling pathway.
Yang G; Wang N; Seto SW; Chang D; Liang H
Brain Res Bull; 2018 Jun; 140():243-257. PubMed ID: 29775658
[TBL] [Abstract][Full Text] [Related]
6. Isorhamnetin protects against hypoxia/reoxygenation-induced injure by attenuating apoptosis and oxidative stress in H9c2 cardiomyocytes.
Zhao TT; Yang TL; Gong L; Wu P
Gene; 2018 Aug; 666():92-99. PubMed ID: 29730426
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor yellow A protects against angiotensin II‑induced hypertrophy.
Ni B; Zhou D; Jing Y; Liu S
Mol Med Rep; 2018 Oct; 18(4):3649-3656. PubMed ID: 30132539
[TBL] [Abstract][Full Text] [Related]
8. Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis.
Ye J; Wang R; Wang M; Fu J; Zhang Q; Sun G; Sun X
Oxid Med Cell Longev; 2021; 2021():6643615. PubMed ID: 34093960
[TBL] [Abstract][Full Text] [Related]
9. Hydroxysafflor yellow A alleviates cerebral ischemia reperfusion injury by suppressing apoptosis via mitochondrial permeability transition pore.
Huang P; Wu SP; Wang N; Seto S; Chang D
Phytomedicine; 2021 May; 85():153532. PubMed ID: 33735723
[TBL] [Abstract][Full Text] [Related]
10. Hydroxysafflor yellow A alleviates myocardial ischemia/reperfusion in hyperlipidemic animals through the suppression of TLR4 signaling.
Han D; Wei J; Zhang R; Ma W; Shen C; Feng Y; Xia N; Xu D; Cai D; Li Y; Fang W
Sci Rep; 2016 Oct; 6():35319. PubMed ID: 27731393
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of hydroxysafflor yellow A alone or in combination with acetylglutamine on cerebral ischemia reperfusion injury in rat: A PET study using
Deng L; Wan H; Zhou H; Yu L; He Y
Eur J Pharmacol; 2018 Apr; 825():119-132. PubMed ID: 29438705
[TBL] [Abstract][Full Text] [Related]
12. Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.
Jiang S; Shi Z; Li C; Ma C; Bai X; Wang C
Int J Clin Exp Pathol; 2014; 7(5):2595-608. PubMed ID: 24966974
[TBL] [Abstract][Full Text] [Related]
13. Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway.
Lv Y; Qian Y; Fu L; Chen X; Zhong H; Wei X
Eur J Pharmacol; 2015 Dec; 769():324-32. PubMed ID: 26607471
[TBL] [Abstract][Full Text] [Related]
14. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
15. [Astragaloside Ⅳ regulates Nrf2/Bach1/HO-1 signaling pathway and inhibits H9c2 cardiomyocyte injury induced by hypoxia-reoxygenation].
Yang P; Zhou YP; Chang XC; Wang F; Li GW
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(11):2331-2337. PubMed ID: 31359660
[TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor Yellow A Reprograms TLR9 Signalling Pathway in Ischaemic Cortex after Cerebral Ischaemia and Reperfusion.
Gong Z; Pan J; Li X; Wang H; He L; Peng Y
CNS Neurol Disord Drug Targets; 2018; 17(5):370-382. PubMed ID: 29732997
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection of hydroxysafflor yellow A in experimental cerebral ischemia/reperfusion injury via metabolic inhibition of phenylalanine and mitochondrial biogenesis.
Chen S; Sun M; Zhao X; Yang Z; Liu W; Cao J; Qiao Y; Luo X; Wen A
Mol Med Rep; 2019 Apr; 19(4):3009-3020. PubMed ID: 30816517
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of hydroxysafflor yellow A on PDGF‑BB‑induced proliferation and migration of vascular smooth muscle cells via mediating Akt signaling.
Song Y; Long L; Zhang N; Liu Y
Mol Med Rep; 2014 Sep; 10(3):1555-60. PubMed ID: 24939805
[TBL] [Abstract][Full Text] [Related]
19. Naringin protects against anoxia/reoxygenation-induced apoptosis in H9c2 cells via the Nrf2 signaling pathway.
Chen RC; Sun GB; Wang J; Zhang HJ; Sun XB
Food Funct; 2015 Apr; 6(4):1331-44. PubMed ID: 25773745
[TBL] [Abstract][Full Text] [Related]
20. Heme oxygenase 1 induction protects myocardiac cells against hypoxia/reoxygenation-induced apoptosis : The role of JNK/c-Jun/Caspase-3 inhibition and Akt signaling enhancement.
Li C; Zhang C; Wang T; Xuan J; Su C; Wang Y
Herz; 2016 Dec; 41(8):715-724. PubMed ID: 27220977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
